Thromb Haemost 1984; 51(02): 186-188
DOI: 10.1055/s-0038-1661054
Original Article
Schattauer GmbH Stuttgart

Dihomo-γ-Linolenic Acid in Patients with Atherosclerosis: Effects on Platelet Aggregation, Plasma Lipids and Low-Density Lipoprotein-Induced Inhibition of Prostacyclin Generation

A Szczeklik
The Department of Medicine, and Pharmacology, Copernicus Academy of Medicine, Cracow, Poland
,
R J Gryglewski
The Department of Medicine, and Pharmacology, Copernicus Academy of Medicine, Cracow, Poland
,
K Sladek
The Department of Medicine, and Pharmacology, Copernicus Academy of Medicine, Cracow, Poland
,
E Kostka-Trąbka
The Department of Medicine, and Pharmacology, Copernicus Academy of Medicine, Cracow, Poland
,
A Żmuda
The Department of Medicine, and Pharmacology, Copernicus Academy of Medicine, Cracow, Poland
› Author Affiliations
Further Information

Publication History

Received 10 October 1983

Accepted 29 December 1983

Publication Date:
19 July 2018 (online)

Preview

Summary

Dihomo-γ-linolenic acid (DHLA), a precursor of monoenoic anti-aggregatory prostaglandins (PGE1, PGD2), was administered for 4 weeks in a daily dose of 1.0 g into 33 patients with atherosclerosis on a basis of a double-blind trial. Comparison of treatment and placebo groups revealed elevation of DHLA in red cell lipids in DHLA-treated subjects. No differences, however, between the two groups could be observed in platelet aggregability, thromboxane A2 generation by platelets, serum cholesterol, PGE1 and PGE2 levels, and in inhibitory activity of low-density lipoproteins against prostacyclin synthetizing system in arteries. The dietary supplementation used did not lead to distinct antithrombotic effects.